Focal adhesion kinase versus p53: Apoptosis or survival?

Science Signaling

Volumn 1, Issue 20, 2008, Pages

  Cance, William G ^a,b,c,d   Golubovskaya, Vita M ^a,b,d  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; PROTEIN P53;

ANIMAL; APOPTOSIS; CELL SURVIVAL; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN BINDING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL SURVIVAL; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MICE; PROTEIN BINDING; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 48849112195     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/stke.120pe22     Document Type: Review

References (31)

1. M. D. Schaller, C. A. Borgman, B. S. Cobb, R. R. Vines, A. B. Reynolds, J. T. Parsons, PP125FAK, a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. Natl. Acad. Sci. U.S.A. 89, 5192-5196 (1992).
2. L. H. Xu, X. Yang, C. A. Bradham, D. A. Brenner, A. S. Baldwin, R. J. Craven, W. G. Cance, The focal adhesion kinase suppresses transformationassociated, anchorage-independent apoptosis in human breast cancer cells. J. Biol. Chem. 275, 30597-30604 (2000).
3. V. M. Golubovskaya, R. Finch, F. Kweh, N. A. Massoll, M. Campbell-Thompson, M. R.Wallace, W. G. Cance, p53 regulates FAK expression in human tumor cells. Mol. Carcinog. 47, 373-382 (2008).
4. T. M.Weiner, E. T. Liu, R. J. Craven, W. G. Cance, Expression of focal adhesion kinase gene and invasive cancer. Lancet 342, 1024-1025 (1993).
5. L. V. Owens, L. Xu, G. A. Dent, X. Yang, G. C. Sturge, R. J. Craven, W. G. Cance, Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann. Surg. Oncol. 3, 100-105 (1996).
6. L. V. Owens, L. Xu, R. J. Craven, G. A. Dent, T. M. Weiner, L. Kornberg, E. T. Liu, W. G. Cance, Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res. 55, 2752-2755 (1995).
7. H. M. Lightfoot, A. Lark, C. A. Livasy, D. T. Moore, D. Cowan, L. Dressler, R. J. Craven, W. G. Cance, Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis. Breast Cancer Res. Treat. 88, 109-116 (2004).
8. A. L. Lark, C. A. Livasy, B. Calvo, L. Caskey, D. T. Moore, X. Yang, W. G. Cance, Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: Immunohistochemistry and real-time PCR analyses. Clin. Cancer Res. 9, 215-222 (2003).
9. W. G. Cance, J. E. Harris, M. V. Iacocca, E. Roche, X. Yang, J. Chang, S. Simkins, L. Xu, Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: Correlation with preinvasive and invasive phenotypes. Clin. Cancer Res. 6, 2417-2423 (2000).
10. V. M. Golubovskaya, R. Finch, W. G. Cance, Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53*. J. Biol. Chem. 280, 25008-25021 (2005).
11. V. M. Golubovskaya, W. G. Cance, Focal adhesion kinase and p53 signaling in cancer cells. Int. Rev. Cytol. 263, 103-153 (2007).
12. S. T. Lim, X. L. Chen, Y. Lim, D. A. Hanson, T. T. Vo, K. Howerton, N. Larocque, S. J. Fisher, D. D. Schlaepfer, D. Ilic, Nuclear FAK promotes cell proliferation and survival through FERMenhanced p53 degradation. Mol. Cell 29, 9-22 (2008).
13. V. Golubovskaya, A. Kaur, W. G. Cance, Cloning and characterization of the promoter region of human focal adhesion kinase gene: Nuclear factor ?B and p53 binding sites. Biochim. Biophys. Acta 1678, 111-125 (2004).
14. V. Golubovskaya, K. Conway-Dorsey, D. Moore, R. Millikan, W. G. Cance, FAK overexpression and p53 mutations positively correlate in a populationbased series of breast cancer tumors. American Association for Cancer Research Proceedings Supplement, late-breaking abstract LB-155, 49, 44 (2008).
15. E. Kurenova, L. H. Xu, X. Yang, A. S. Baldwin Jr., R. J. Craven, S. K. Hanks, Z.-g. Liu, W. G. Cance, Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein. Mol. Cell. Biol. 24, 4361-4371 (2004).
16. B. Z. Stanger, P. Leder, T. H. Lee, E. Kim, B. Seed, RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81, 513-523 (1995).
17. M. A. Kelliher, S. Grimm, Y. Ishida, F. Kuo, B. Z. Stanger, P. Leder, The death domain kinase RIP mediates the TNF-induced NF-?B signal. Immunity 8, 297-303 (1998).
18. S. Frisch, personal communication.
19. D. J. Sieg, C. R. Hauck, D. Ilic, C. K. Klingbeil, E. Schaefer, C. H. Damsky, D. D. Schlaepfer, FAK integrates growth factor and integrin signals to promote cell migration. Nat. Cell Biol. 2, 249-256 (2000).
20. V. Golubovskaya, L. Beviglia, L. H. Xu, H. S. Earp III, R. Craven, W. Cance, Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells. J. Biol. Chem. 277, 38978-38987 (2002).
21. S. Y. Chen, H. C. Chen, Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion. Mol. Cell. Biol. 26, 5155-5167 (2006).
22. C. A. Garces, E. V. Kurenova, V. M. Golubovskaya, W. G. Cance, Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells. Cancer Res. 66, 1446-1454 (2006).
23. L. Beviglia, V. Golubovskaya, L. Xu, X. Yang, R. J. Craven, W. G. Cance, Focal adhesion kinase Nterminus in breast carcinoma cells induces rounding, detachment and apoptosis. Biochem. J. 373, 201-210 (2003).
24. G. Jones, J. Machado Jr., A. Merlo, Loss of focal adhesion kinase (FAK) inhibits epidermal growth factor receptor-dependent migration and induces aggregation of nh(2)-terminal FAK in the nuclei of apoptotic glioblastoma cells. Cancer Res. 61, 4978-4981 (2001).
25. G. Jones, G. Stewart, Nuclear import of N-terminal FAK by activation of the FcεRI receptor in RBL-2H3 cells. Biochem. Biophys. Res. Commun. 314, 39-45 (2004).
26. M. Lobo, I. Zachary, Nuclear localization and apoptotic regulation of an amino-terminal domain focal adhesion kinase fragment in endothelial cells. Biochem. Biophys. Res. Commun. 276, 1068-1074 (2000).
27. G. Kadare, M. Toutant, E. Formstecher, J. C. Corvol, M. Carnaud, M. C. Boutterin, J. A. Girault, PIAS1-mediated sumoylation of focal adhesion kinase activates its autophosphorylation. J. Biol. Chem. 278, 47434-47440 (2003).
28. J. E. Chipuk, D. R. Green, Cytoplasmic p53: Bax and Forward. Cell Cycle 3, 429-431 (2004).
29. J. E. Chipuk, T. Kuwana, L. Bouchier-Hayes, N. M. Droin, D. D. Newmeyer, M. Schuler, D. R. Green, Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303, 1010-1014 (2004).
30. V. Golubovskaya, R. Finch, M. Zheng, E. V. Kurenova, W. G. Cance, The 7 amino-acid site in the proline-rich region of the N-terminal domain of p53 is involved in interaction with FAK and is critical for p53 functioning. Biochem. J. 411, 151-160 (2008).
31. W. G. Cance, V. M. Golubovskaya, Focal adhesion kinase versus p53: Apoptosis or survival? Sci. Signal. 1, pe22 (2008).